Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Molecular profiling identifies at least 3 distinct types of post-transplant lymphoproliferative disorder involving CNS

PROVIDER: PRJNA950018 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24005734.fastq.gz	Fastqsanger.gz
	SRR24005734_1.fastq.gz	Fastqsanger.gz
	SRR24005734_2.fastq.gz	Fastqsanger.gz
	SRR24005735.fastq.gz	Fastqsanger.gz
	SRR24005735_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 42

Similar Datasets

Project description:Virome sequencing in post-transplant lymphoproliferative disorder

| PRJNA488282 | ENA

Homo sapiens

Project description:Expression data from post-transplant lymphoproliferative disorder (PTLD) patient samples

| PRJNA169160 | ENA

Lymphocryptovirus sp.

Project description:Cynomolgus Lymphocryptovirus Isolate from a Macaque with Post-transplant Lymphoproliferative Disorder

| PRJNA809704 | ENA

Pediatric post-transplant lymphoproliferative disorders

Project description:Unravelling the heterogenous molecular landscape of pediatric post-transplant lymphoproliferative disorders

| PRJEB50295 | ENA

Unravelling the heterogeneous molecular landscape of pediatric post-transplant lymphoproliferative disorders

Project description:Unravelling the heterogeneous molecular landscape of pediatric post-transplant lymphoproliferative disorders

| PRJNA814282 | ENA

PTLD

Project description:Investigating the heterogeneity of Post-Transplant Lymphoproliferative Disease (PTLD)

| PRJEB75827 | ENA

Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy

Project description:The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) after failure of rituximab and rituximab plus chemotherapy or (2) allogeneic hematopoietic cell transplant (HCT) after failure of rituximab.

| 2262897 | ecrin-mdr-crc

Human miRNA expression in EBV+ and EBV- PTLD tumor tissue sections

Project description:Expression of human miRNAs was analyzed in 150 ng of total RNA from nine post-transplant lymphoproliferative disorder (PTLD) patient samples, categorized as Epstein-Barr virus-positive (EBV+ , n = 4) or EBV- (n = 5) PTLD by hybridization on Affymetrix’s GeneChip miR Array 4.0 (Stanford Functional Genomics Facility, Stanford, CA). The Bioconductor ‘oligo’ package was used to perform array background subtraction, quantile normalization, and summarization by median polish. The normalized gene expression dataset was annotated with the ‘pd.mirna.4.0’ annotation library package in R (R Core Team). The expression data was fit to a linear model using the ‘stats’ package in R (R Core Team). Moderated t-statistics and log-odds of differential expression were calculated using the empirical Bayes method. False discovery rate (FDR) tests were performed with the Benjamini-Hochberg procedure for multiple testing correction in R (R Core Team).

2022-10-31 | E-MTAB-12201 | biostudies-arrayexpress

Cell type-specific gene expression profiles in CNS of patients with DM1

Project description:Myotonic dystrophy type 1 (DM1) is a multisystem genetic disorder involving the muscle, heart, and central nervous system (CNS). The pathogenesis of CNS symptoms prevalent in patients with DM1 remains unelucidated. To elucidate the CNS pathogenesis in DM1, we investigated cell type-specific abnormalities in cortical neurons, white matter glial cells, and spinal motor neurons of patients with DM1 via laser-capture microdissection(LCM).

2022-07-07 | GSE198321 | GEO

Homo sapiens

Project description:Comparative whole genome profiling of post-transplant lymphoproliferative disorders and diffuse large B-cell lymphomas.

| PRJNA101001 | ENA